Simcere Pharmaceutical Group Ltd. engages in the research, development, manufacturing, and sale of pharmaceutical products. The company is headquartered in Nanjing, Jiangsu and currently employs 6,815 full-time employees. The company went IPO on 2020-10-27. The firm's main products are generic drugs, including Bicun used for central nervous system diseases, Jepaso and Jiebaili used for oncology, as well as Yingtaiqing used for autoimmune diseases. The firm also produces various drugs, including Endostar used for oncology. The firm is also involved in providing promotion services for third-party drugs sold by medical institutions. The firm mainly conducts its businesses in the domestic market and overseas markets.
02096.HK stock price ended at $12.28 on Perşembe, after dropping 3.08%
On the latest trading day Feb 12, 2026, the stock price of 02096.HK fell by 3.08%, dropping from $12.56 to $12.28. During the session, the stock saw a volatility of 3.70%, with prices oscillating between a daily low of $12.17 and a high of $12.62. On the latest trading day, the trading volume for 02096.HK rose by 316.5K shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 4.6M shares were traded, with a market value of approximately $31.8B.
02096.HKTeknik Sinyalleri
Teknik Sinyaller Özeti
Satın Alma Sinyalleri 3
Nötr Sinyaller 1
Satış Sinyalleri 3
Strong Sell
Sell
Neutral
Buy
Strong Buy
02096.HK, şu anda 3 alım sinyali ve 3 satım sinyali vermektedir. Hisse senedi 12:00 AM'ten beri Aşağı yönlü trend durumundadır ve bu dönemde toplam -3.08% fiyat değişimi gerçekleşti. Genel olarak teknik göstergeler orta vadeli olarak Neutral görünüm işaret etmektedir.
02096.HK için Boğa/Ayı Sinyalleri
Hareketli ortalamalar, RSI, MACD ve işlem hacmi gibi temel göstergeleri analiz ederek 02096.HK için yükseliş ve düşüş sinyalleri üretiyoruz. Bu analizlerle daha bilinçli yatırım kararları verin.